Molnupiravir helps stop Sars cov 2, but can cause mutagenesis to your cells | Molnupiravir 有助於阻止 Sars cov 2，但會導致細胞發生突變

Many stduies have already been conducted to understand how Molnupiravir does to stop Sars Cov 2. It is found that the antiviral drug is actually an mutagen (an analog to an essential nucleotide element that is used to make DNA or mRNA) that causes mutagenesis in viral genetics. With this analog inserted into the native genetic sequence, the genetic coding is disrupted, leading to the stoppage of the viral repetition.

The problem is, this drug active ingredient can do the same damage to the human DNA causing mutagenesis and further carcinogensis or causing cancer.  Those who are concerned may read this study for details.

Also watch a video here.

默克公司正在為其抗病毒藥物 Molnupiravir 尋求緊急使用授權。 新聞爆出美國。 政府已經訂購了超過 1000 萬劑。

許多標準研究人員已經開始了解 Molnupiravir 如何阻止 Sars Cov 2。 發現抗病毒藥物實際上是一種誘變劑（一種用於製造 DNA 或 mRNA 的基本核苷酸元件的類似物），會導致病毒遺傳學發生突變 . 將這種類似物插入天然基因序列後，基因編碼被破壞，導致病毒重複停止。

問題是，這種藥物活性成分可以對人類 DNA 造成同樣的損害，導致突變，進而可能致癌或致癌。 有興趣的朋友可以閱讀本研究了解詳情。

β-d-N4-羥基胞苷通過致死誘變抑制 SARS-CoV-2，但對哺乳動物細胞也具有誘變作用。